Author

Khaled Junaidi

Observed name: KHALED JUNAIDI

Observed institution: Xeris Pharmaceuticals (United States)

ORCID: 0000-0003-0581-5412

Observed ORCID: 0000-0003-0581-5412

OpenAlex ID: A5010087451

Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies

2021 · Mark P Christiansen, Martin Cummins, et al. · BMJ Open Diabetes Research & Care · 22

Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes

2022 · Thomas R. Pieber, Ronnie Aronson, et al. · Diabetes Obesity and Metabolism · 8

734-P: VRB101 Is a Potent Oral GLP-1 Tablet with Once-Weekly Dosing Potential

2025 · MARTIJN FENAUX, ERIC ADEGBITE, et al. · Diabetes

Author response for "Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus as a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes"

2022 · Thomas R. Pieber, Ronnie Aronson, et al.

MON-LB115 Ready-To-Use Glucagon for the Prevention of Exercise-Induced Hypoglycemia in a Clinical Research Setting

2020 · Ronnie Aronson, Michael Riddell, et al. · Journal of the Endocrine Society

MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure

2020 · Jeremy H Pettus, Samer Nakhle, et al. · Journal of the Endocrine Society

SAT-272 A Phase 2 Comparison of a Stable Liquid Glucagon to Placebo for the Treatment of Congenital Hyperinsulinism

2019 · Paul Thornton, Martin Cummins, et al. · Journal of the Endocrine Society

Works count: 7

Citation count: 29

H-index: 2

I10-index: 1